Evidence map›Paper›PMID 28404743›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2017

Nuclear complex of glyceraldehyde-3-phosphate dehydrogenase and DNA repair enzyme apurinic/apyrimidinic endonuclease I protect smooth muscle cells against oxidant-induced cell death.

Xuwei Hou, Patricia Snarski, Yusuke Higashi, Tadashi Yoshida, Alexander Jurkevich, Patrick Delafontaine, Sergiy Sukhanov

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Exploring the Mechanisms ofInternational journal of molecular sciences · 2025
    Article
  3. Review
  4. Review
  5. Targeting Moonlighting Enzymes in Cancer.Molecules (Basel, Switzerland) · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. APE1 inhibits foam cell formation from macrophages via LOX1 suppression.American journal of translational research · 2020
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xuwei HouDepartment of Medicine, School of Medicine, University of Missouri at Columbia, Columbia, Missouri, USA.
Patricia SnarskiDepartment of Medicine, School of Medicine, University of Missouri at Columbia, Columbia, Missouri, USA.
Yusuke HigashiDepartment of Medicine, School of Medicine, University of Missouri at Columbia, Columbia, Missouri, USA.
Tadashi YoshidaDepartment of Medicine, School of Medicine, University of Missouri at Columbia, Columbia, Missouri, USA.
Alexander JurkevichMolecular Cytology Core, University of Missouri at Columbia, Columbia, Missouri, USA.
Patrick DelafontaineDepartment of Medicine, School of Medicine, University of Missouri at Columbia, Columbia, Missouri, USA.
Sergiy SukhanovDepartment of Medicine, School of Medicine, University of Missouri at Columbia, Columbia, Missouri, USA; sukhanovs@health.missouri.edu.
University of Missouri · US

Funding

VASCULAR SMOOTH MUSCLE PLASTICITY IN NITRIC OXIDEP20RR018766 · NCRR · LSU HEALTH SCIENCES CENTER · PI WORTHYLAKE, REBECCA · 2003 to 2011
$18.5M
Insulin-Like Growth Factor-1and AtherosclerosisR01HL070241 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI PATRICE DELAFONTAINE · 2003 to 2026
$10.1M
ANGIOTENSIN II, IGF-1 AND SKELETAL MUSCLE ATROPHYR01HL080682 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI DELAFONTAINE, PATRICE · 2007 to 2015
$3.3M
12/15-LIPOXYGENASE, INSULIN-LIKE GROWTH FACTOR-1 AND ATHEROSCLEROSISR21HL113705 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI SUKHANOV, SERGIY · 2013 to 2014
$399k
NCRR NIH HHS P20 RR018766NHLBI NIH HHS R01 HL070241NHLBI NIH HHS R01 HL080682NHLBI NIH HHS R21 HL113705
6 · The paper itself

Abstract

Atherosclerotic plaque destabilization is the major determinant of most acute coronary events. Smooth muscle cell (SMC) death contributes to plaque destabilization. Here, we describe a novel antiapoptotic mechanism in vascular SMCs that involves interaction of nuclear glyceraldehyde-3-phosphate dehydrogenase (GAPDH) with apurinic/apyrimidinic endonuclease 1 (Ape1), the major oxidized DNA repair enzyme. GAPDH down-regulation potentiated H

Indexed as

Active Transport, Cell NucleusAnimalsApolipoproteins ECell DeathCell NucleusDNA-(Apurinic or Apyrimidinic Site) LyaseGene Expression Regulation, EnzymologicGlyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)Hydrogen PeroxideMiceMice, KnockoutMyocytes, Smooth MuscleRatsApex1 protein, mouseApex1 protein, ratApolipoproteins EDNA-(Apurinic or Apyrimidinic Site) LyaseGlyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)Hydrogen PeroxideapoptosisGAPDHoxidative stress

Identifiers

PMID28404743
PMCPMC5471514
OpenAlexW2605727846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.